Get the Stockscreener App
1.72
1.15%
-0.02
After Hours:
1.72
Fortress Biotech Inc Stock (FBIO) Forecast
The Fortress Biotech Inc (FBIO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.1751, representing a +26.46% increase from the current price of $1.72. The highest analyst price target is $2.7051, and the lowest is $1.6451.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FBIO Price Target
Average 2.8902
(+68.04% Upside)
Is Fortress Biotech Inc (FBIO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.52 | Neutral |
| STOCH(9,6) | 5.4197 | Buy |
| STOCHRSI(14) | 2.3457 | Buy |
| MACD(12,26) | -0.00198 | Sell |
| ADX(14) | 20.21 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | -72.59 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.926
Sell
|
1.862
Sell
|
| MA20 |
1.9563
Sell
|
1.8853
Sell
|
| MA50 |
1.8256
Sell
|
1.8446
Sell
|
| MA100 |
1.8065
Sell
|
1.8299
Sell
|
| MA200 |
1.8447
Sell
|
1.8113
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, FBIO could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on FBIO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.52 indicates that FBIO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 5.4197 indicates that FBIO is oversold. This indicates that FBIO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.3457 indicates that FBIO is oversold. This suggests that FBIO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.21 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -72.59 indicates that FBIO is still oversold but not to an extreme extent.
Long-term FBIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Fortress Biotech Inc financial reports and earnings history, Fortress Biotech Inc (FBIO) stock could reach $1.95 by 2030, $0.7177 by 2040 and $1.4882 by 2050. See the projected annual prices until 2050 of the Fortress Biotech Inc stock below:
- Fortress Biotech Inc (FBIO) is expected to reach an average price of $2.1121 in 2035, with a high prediction of $2.7521 and a low estimate of $1.152. This indicates an $22.79% rise from the last recorded price of $1.72.
- Fortress Biotech Inc (FBIO) stock is projected to chart a bullish course in 2040, with an average price target of $0.6347, representing an $-63.10% surge from its current level. The forecast ranges from a conservative $0.5677 to a sky-high $0.7177.
- Our analysts predict Fortress Biotech Inc (FBIO) to jump -59.12% by 2045, soaring from $0.5751 to an average price of $0.7031, potentially reaching $0.983. While $0.5751 is the low estimate, the potential upside is significant.
- Fortress Biotech Inc (FBIO) stock is expected to climb by 2050, reaching an average of $1.2582, a $-26.85% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.4882 and $1.0082, respectively, highlighting the market's uncertainty.
Fortress Biotech Inc Stock (FBIO) Year by Year Forecast
Fortress Biotech Inc Stock (FBIO) Price Forecast for 2025
Fortress Biotech Inc Stock (FBIO) is expected to reach an average price of $2.8902 in 2025, with a high prediction of $4.7353 and a low estimate of $1.0452. This indicates an +68.04% rise from the last recorded price of $1.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.6601 | $1.6451 | $2.7051 | +54.66% |
| February, 2025 | $2.1952 | $1.9752 | $2.8952 | +27.63% |
| March, 2025 | $2.0552 | $1.9152 | $3.0652 | +19.49% |
| April, 2025 | $1.7952 | $1.0452 | $2.1952 | +4.37% |
| May, 2025 | $2.1652 | $1.6952 | $2.3952 | +25.88% |
| June, 2025 | $2.5252 | $1.8452 | $2.7052 | +46.82% |
| July, 2025 | $2.9752 | $2.4252 | $3.1452 | +72.98% |
| August, 2025 | $2.6653 | $2.4853 | $3.0403 | +54.96% |
| September, 2025 | $2.9953 | $2.5653 | $3.4053 | +74.14% |
| October, 2025 | $3.6953 | $2.8753 | $4.1349 | +114.84% |
| November, 2025 | $3.9853 | $3.5553 | $4.7353 | +131.70% |
| December, 2025 | $2.1553 | $2.1203 | $4.7253 | +25.31% |
Fortress Biotech Inc Stock (FBIO) Price Forecast for 2026
The predicted value for Fortress Biotech Inc (FBIO) in 2026 is set at an average of $4.0654. Estimates vary from a peak of $6.0554 to a trough of $2.0753, indicating an +136.36% surge from the present price of $1.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.7253 | $2.0753 | $2.8353 | +58.45% |
| February, 2026 | $3.2754 | $2.3154 | $3.3854 | +90.43% |
| March, 2026 | $3.3254 | $2.9654 | $3.6454 | +93.34% |
| April, 2026 | $4.3154 | $3.0854 | $4.317 | +150.90% |
| May, 2026 | $4.1654 | $3.5054 | $5.0354 | +142.18% |
| June, 2026 | $5.3954 | $3.2254 | $5.7354 | +213.69% |
| July, 2026 | $3.6354 | $3.4455 | $6.0554 | +111.36% |
| August, 2026 | $4.4455 | $3.4055 | $4.4455 | +158.46% |
| September, 2026 | $3.4255 | $3.2455 | $4.0055 | +99.16% |
| October, 2026 | $3.2855 | $2.9405 | $3.4682 | +91.02% |
| November, 2026 | $3.2455 | $2.7555 | $3.3355 | +88.69% |
| December, 2026 | $3.1755 | $3.0655 | $3.7655 | +84.62% |
Fortress Biotech Inc Stock (FBIO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Fortress Biotech Inc (FBIO) is $2.1861, with a high forecast of $3.6456 and a low forecast of $0.7267. This indicates an +27.10% increase from the last price of $1.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.9655 | $2.8305 | $3.2551 | +72.42% |
| February, 2027 | $3.0456 | $2.9456 | $3.6456 | +77.07% |
| March, 2027 | $2.4756 | $2.3266 | $3.0706 | +43.93% |
| April, 2027 | $2.2656 | $2.1606 | $2.7356 | +31.72% |
| May, 2027 | $1.8656 | $1.8156 | $2.2656 | +8.47% |
| June, 2027 | $1.3256 | $1.2956 | $2.0556 | -22.93% |
| July, 2027 | $1.3156 | $1.1856 | $1.4856 | -23.51% |
| August, 2027 | $1.0057 | $0.9757 | $1.4807 | -41.53% |
| September, 2027 | $0.8561 | $0.7457 | $1.1857 | -50.23% |
| October, 2027 | $0.7557 | $0.7267 | $1.0457 | -56.06% |
| November, 2027 | $0.8807 | $0.7557 | $1.0257 | -48.80% |
| December, 2027 | $1.2257 | $0.7957 | $1.2807 | -28.74% |
Fortress Biotech Inc Stock (FBIO) Price Forecast for 2028
In 2028, Fortress Biotech Inc (FBIO) is projected to reach an average price of $0.8409, with a high projection of $1.2457 and a low estimate of $0.436. This indicates an -51.11% fall from the last price of $1.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0257 | $0.9109 | $1.2457 | -40.36% |
| February, 2028 | $0.8158 | $0.7078 | $1.1158 | -52.57% |
| March, 2028 | $0.7859 | $0.6258 | $0.9268 | -54.31% |
| April, 2028 | $0.6808 | $0.6668 | $0.8463 | -60.42% |
| May, 2028 | $0.5044 | $0.4822 | $0.6958 | -70.67% |
| June, 2028 | $0.9858 | $0.436 | $1.1158 | -42.68% |
| July, 2028 | $0.7158 | $0.6568 | $1.0273 | -58.38% |
| August, 2028 | $0.6759 | $0.6009 | $0.8559 | -60.71% |
| September, 2028 | $0.6809 | $0.6559 | $0.791 | -60.41% |
| October, 2028 | $0.6884 | $0.6559 | $0.8059 | -59.98% |
| November, 2028 | $0.4959 | $0.4409 | $0.7228 | -71.17% |
| December, 2028 | $0.5059 | $0.4766 | $0.6659 | -70.59% |
Fortress Biotech Inc Stock (FBIO) Price Forecast for 2029
The 2029 price forecast for Fortress Biotech Inc Stock (FBIO) is $2.4163 on average, with a high prediction of $4.596 and a low estimate of $0.2366. This represents an +40.48% increase from the previous price of $1.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.526 | $0.4469 | $0.6459 | -69.42% |
| February, 2029 | $0.3484 | $0.3367 | $0.556 | -79.75% |
| March, 2029 | $0.306 | $0.2671 | $0.373 | -82.21% |
| April, 2029 | $2.856 | $0.2366 | $4.596 | +66.05% |
| May, 2029 | $1.266 | $1.196 | $2.986 | -26.39% |
| June, 2029 | $2.126 | $1.236 | $2.796 | +23.61% |
| July, 2029 | $2.966 | $2.106 | $4.386 | +72.44% |
| August, 2029 | $1.9961 | $1.6148 | $3.0261 | +16.05% |
| September, 2029 | $1.6961 | $1.5861 | $2.0361 | -1.39% |
| October, 2029 | $1.8911 | $1.5861 | $2.5711 | +9.95% |
| November, 2029 | $1.7061 | $1.5867 | $2.1261 | -0.81% |
| December, 2029 | $1.695 | $1.43 | $1.7761 | -1.45% |
Fortress Biotech Inc Stock (FBIO) Price Forecast for 2030
Fortress Biotech Inc Stock (FBIO) is expected to reach an average price of $2.0104 in 2030, with a high forecast of $3.0203 and a low forecast of $1.0004. This signifies an +16.88% surge from the last price of $1.72.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.60 | $1.48 | $1.95 | -6.97% |
| February, 2030 | $1.4651 | $1.3311 | $1.79 | -14.82% |
| March, 2030 | $1.3101 | $1.1301 | $1.4701 | -23.83% |
| April, 2030 | $1.7301 | $1.1401 | $1.8601 | +0.59% |
| May, 2030 | $1.3402 | $1.2502 | $1.9601 | -22.08% |
| June, 2030 | $1.2902 | $1.1202 | $1.4302 | -24.99% |
| July, 2030 | $1.8302 | $1.1902 | $1.8802 | +6.41% |
| August, 2030 | $2.2403 | $1.6003 | $2.3403 | +30.25% |
| September, 2030 | $2.3603 | $1.9303 | $2.6603 | +37.23% |
| October, 2030 | $2.8403 | $2.0903 | $3.0203 | +65.14% |
| November, 2030 | $1.2505 | $1.0904 | $3.0203 | -27.30% |
| December, 2030 | $1.7704 | $1.0004 | $1.8504 | +2.93% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):